Enfermedad renal crónica
4 min de lectura
GLP-1 receptor agonists' cardiorenal effects in chronic kidney disease: systematic review and meta-analysis (summary)
A systematic review and meta-analysis of randomized trials found that GLP-1 receptor agonists in CKD patients, predominantly with type 2 diabetes, were associated with lower rates of major…
